Conformation‐Driven Dual‐Stage Thermal Antiglycation by Pseudo C 2 ‐Symmetric bis ‐Arylaldimine Scaffold
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Santu Bhunia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry (UG & PG), and Midnapore College Research Centre, Midnapore College (Autonomous), Midnapore (Paschim), West Bengal, India. Hauptthemen laut MEDLINE: Serum Albumin, Bovine, Temperature, Benzaldehydes. Die Arbeit nennt 64 Literaturangaben. Gefördert von: Rashtriya Uchchatar Shiksha Abhiyan (RUSA) 2.0, Component 8 Scheme, Ministry of Human Resource Development, Government of India.
Abstract (Originalsprache)
Chronic hyperglycemia brings forth a cascade of complications in diabetes through reactive dicarbonyls that drive mid‐stage Amadori‐glycoxidation and end‐crosslinking glycation. This study imparts specifically on dual‐stage inhibition of bovine serum albumin (BSA) glycation using a conformation‐driven interactions at the molecular level. A combination of multi‐spectroscopic, physico‐biochemical, and computational studies display significant antiglycation activity (IC 50 17.9 µM) in both BSA/fructose and BSA/methyl glyoxal (MGO) models by pseudo‐ C 2 ‐symmetric vanillin bis ‐aldimine (VBA‐ 1 ) as a privileged Schiff base scaffold. Conformational analysis accompanying with docking and molecular dynamic simulation suggests a probable transoid–cisoid equilibrium through which a unique rotameric s‐trans conformation facilitates selective binding at IIA subdomain of BSA. This subsequently prevents glycation by modulating micro‐environment and minimizing aggregation. Temperature‐assisted glycation and time‐resolved fluorescence demonstrate a dynamic mode of binding with favorable entropy. The study further explores to identify key residues, polar contacts, micro‐environment, excited state analyses, and misfolding mechanisms. These findings emphasize bis ‐arylaldinine (BA) scaffold as a promising lead for therapeutic intervention in glycation‐induced diabetic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry (UG & PG), and Midnapore College Research Centre, Midnapore College (Autonomous), Midnapore (Paschim), West Bengal, India.
- Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata, West Bengal, India.
- Research Centre, Ramkrishna Mission Swami Vivekananda's Ancestral House and Cultural Centre, Kolkata, West Bengal, India.
ORCID-Profile: Santu Bhunia, Arindam Bankura, Charu Chand Hansda, Soumyajit Ghosh, Sansa Dutta, Ranjan Jana, Koushik Chandra
Förderung
- Rashtriya Uchchatar Shiksha Abhiyan (RUSA) 2.0, Component 8 Scheme, Ministry of Human Resource Development, Government of India
Zitieren
APA
Bhunia, S., Bankura, A., Das, S., Hansda, C. C., Ghosh, S., Dutta, S., Jana, R., & Chandra, K. (2025). Conformation‐Driven Dual‐Stage Thermal Antiglycation by Pseudo C 2 ‐Symmetric bis ‐Arylaldimine Scaffold. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500960
Vancouver
Bhunia S, Bankura A, Das S, Hansda CC, Ghosh S, Dutta S, et al. Conformation‐Driven Dual‐Stage Thermal Antiglycation by Pseudo C 2 ‐Symmetric bis ‐Arylaldimine Scaffold. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500960
BibTeX
@article{Bhunia2025,
author = {Bhunia, Santu and Bankura, Arindam and Das, Subhodeep and Hansda, Charu Chand and Ghosh, Soumyajit and Dutta, Sansa and Jana, Ranjan and Chandra, Koushik},
title = {Conformation‐Driven Dual‐Stage Thermal Antiglycation by Pseudo C 2 ‐Symmetric bis ‐Arylaldimine Scaffold},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500960}
}
EUVIMED